JP Morgan Maintains Overweight on Glaukos, Lowers Price Target to $65

JP Morgan maintains Glaukos (NYSE:GKOS) with a Overweight and lowers the price target from $90 to $65.

Benzinga · 12/20/2019 14:46

JP Morgan maintains Glaukos (NYSE:GKOS) with a Overweight and lowers the price target from $90 to $65.